PIERCING ASSOCIATED COMPLICATION

PIERCING ASSOCIATED COMPLICATION was reported 18 times

PIERCING ASSOCIATED COMPLICATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 2 0.0001
1 Estrogen Receptor Antagonist [EPC] 2 0.0000
2 Human Immunoglobulin G [EPC] 1 0.0000
3 Interleukin-17A Antagonist [EPC] 1 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
5 GLP-1 Receptor Agonist [EPC] 2 0.0000
6 Opioid Agonist [EPC] 1 0.0000
7 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
8 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000